In a recent study, mesothelin, mucin 4 (MUC4), annexin A10 (ANXA10), and glypican 1 (GPC-1) were observed to be selectively expressed in the tumor when compared to non-neoplastic pancreatic ducts and acini [47]. This evidence concerns the gene MSLN and neoplasm.